Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EVOLOCUMAB Cause Blood pressure abnormal? 126 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Blood pressure abnormal have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.

126
Reports of Blood pressure abnormal with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
1
Deaths
18
Hospitalizations

How Dangerous Is Blood pressure abnormal From EVOLOCUMAB?

Of the 126 reports, 1 (0.8%) resulted in death, 18 (14.3%) required hospitalization, and 2 (1.6%) were considered life-threatening.

Is Blood pressure abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 126 reports have been filed with the FAERS database.

What Other Side Effects Does EVOLOCUMAB Cause?

Device difficult to use (31,807) Drug dose omission by device (23,957) Wrong technique in product usage process (21,664) Accidental exposure to product (16,160) Injection site pain (9,988) Product storage error (6,606) Back pain (5,254) Myalgia (5,061) Drug dose omission (4,914) Injection site bruising (4,409)

What Other Drugs Cause Blood pressure abnormal?

ADALIMUMAB (625) SACUBITRIL\VALSARTAN (616) TOFACITINIB (472) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (448) LENALIDOMIDE (416) ETANERCEPT (393) TREPROSTINIL (310) AMLODIPINE (240) VALSARTAN (238) METOPROLOL (219)

Which EVOLOCUMAB Alternatives Have Lower Blood pressure abnormal Risk?

EVOLOCUMAB vs EXELON EVOLOCUMAB vs EXEMESTANE EVOLOCUMAB vs EXENATIDE EVOLOCUMAB vs EXFORGE EVOLOCUMAB vs EXJADE

Related Pages

EVOLOCUMAB Full Profile All Blood pressure abnormal Reports All Drugs Causing Blood pressure abnormal EVOLOCUMAB Demographics